losartan has been researched along with Dextro-Looped Transposition of the Great Arteries in 2 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dore, A | 1 |
| Houde, C | 1 |
| Chan, KL | 1 |
| Ducharme, A | 1 |
| Khairy, P | 1 |
| Juneau, M | 1 |
| Marcotte, F | 1 |
| Mercier, LA | 1 |
| Lester, SJ | 1 |
| McElhinney, DB | 1 |
| Viloria, E | 1 |
| Reddy, GP | 1 |
| Ryan, E | 1 |
| Tworetzky, W | 1 |
| Schiller, NB | 1 |
| Foster, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prospective Comparison of ARNI Versus plAcebo in Patients With Congenital sYStemic Right Ventricle Heart Failure[NCT05117736] | 48 participants (Anticipated) | Interventional | 2022-03-15 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for losartan and Dextro-Looped Transposition of the Great Arteries
| Article | Year |
|---|---|
Angiotensin receptor blockade and exercise capacity in adults with systemic right ventricles: a multicenter, randomized, placebo-controlled clinical trial.
Topics: Adult; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Cross-Over Studies; Double-Blind Met | 2005 |
Effects of losartan in patients with a systemically functioning morphologic right ventricle after atrial repair of transposition of the great arteries.
Topics: Adolescent; Angiotensin Receptor Antagonists; Cross-Over Studies; Hemodynamics; Humans; Losartan; Tr | 2001 |